NCT02254317View on ClinicalTrials.gov

Dose-dependent Effect of Grape Seed Extract on Glucose Control in People With Impaired Glucose Tolerance

NACompletedINTERVENTIONAL
Enrollment

16

Participants

Timeline

Start Date

September 15, 2014

Primary Completion Date

June 27, 2015

Study Completion Date

July 1, 2015

Conditions
Impaired Glucose Tolerance
Interventions
DIETARY_SUPPLEMENT

0 mg placebo

Not containing GSE (Placebo)

DIETARY_SUPPLEMENT

300 mg GSE

300 mg GSE

DIETARY_SUPPLEMENT

600 mg GSE

Containing 600 mg of GSE

DIETARY_SUPPLEMENT

900 mg GSE

Containing 900 mg of GSE

Trial Locations (1)

60616

Eunyoung Park, Chicago

All Listed Sponsors
lead

Clinical Nutrition Research Center, Illinois Institute of Technology

INDUSTRY

NCT02254317 - Dose-dependent Effect of Grape Seed Extract on Glucose Control in People With Impaired Glucose Tolerance | Biotech Hunter | Biotech Hunter